|
Volumn 92, Issue 5, 2001, Pages 1101-1107
|
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors
|
Author keywords
Chemotherapy; Cisplatin; Etoposide; Metastatic neuroendocrine tumors; Nephrotoxicity
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
GAMMA INTERFERON;
SOMATOSTATIN;
STREPTOZOCIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER GROWTH;
CARCINOID;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE COURSE;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
MALE;
METASTASIS;
NEPHROTOXICITY;
NEUROENDOCRINE TUMOR;
PRIORITY JOURNAL;
ABDOMINAL NEOPLASMS;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL MARKERS;
CARCINOMA, NEUROENDOCRINE;
CISPLATIN;
ETOPOSIDE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
SURVIVAL ANALYSIS;
|
EID: 0035447766
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V Document Type: Article |
Times cited : (225)
|
References (13)
|